Evidence map›Paper›PMID 42899135›Full record

ArticleFrontiers in microbiology2026

Comparison of three routine methods for the identification of

Lara Purschwitz, Boyke Bunk, Percy Schröttner

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lara PurschwitzInstitute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Boyke BunkLeibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH, Braunschweig, Germany.
Percy SchröttnerInstitute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Since its first description in 2003, clinical case reports have repeatedly documented that the bacterial species Methods: The aim of this study is to determine the most appropriate method for identifying Results: The results show that MALDI-TOF MS is best suited for identifying Discussion: MALDI-TOF MS is well suited for expanding the reference collection directly from routine diagnostics. The results of 16S gene sequencing should be interpreted with caution. Conversely, biochemical methods must be regarded as unreliable. The species' large core genome suggests a specialized previously unknown specialized ecological niche. Furthermore, two distinct clusters within the reference collection suggest a common origin. Additionally, follow-up studies must determine whether one isolate that cannot be unambiguously assigned to a species represents a previously undescribed member of the genus Kerstersia.

Indexed as

dDDHKerstersia gyiorumMALDI TOF MSNGSsequencing of the 16S rRNA geneVITEK 2

Identifiers

PMID42899135
PMCPMC13679296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.